Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazatomprom S Regulatory News (KAP)

Share Price Information for Kazatomprom S (KAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.75
Ask: 40.85
Change: 0.45 (1.12%)
Spread: 0.10 (0.245%)
Open: 40.30
High: 41.20
Low: 40.20
Prev. Close: 40.30
KAP Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Cases at KATCO JV

20 Jan 2021 12:25

RNS Number : 3430M
JSC National Atomic Co. Kazatomprom
20 January 2021
 

AIX: KAP, KAP.Y (GDR)

LSE: KAP (GDR)

Currency: KZT (₸), unless otherwise noted

 

 

20 January 2021, Nur-Sultan, Kazakhstan

COVID-19 Cases at KATCO JV

JSC National Atomic Company "Kazatomprom" ("Kazatomprom" or "the Company") announces that several positive cases of COVID-19 have been identified at the Company's Kazakh-French Joint Venture, KATCO LLC ("KATCO"), operating in the Turkestan region of the Republic of Kazakhstan.

The Company's mandatory COVID-19 protocols were deployed early in the pandemic, including extended shift durations, PCR testing before and after shifts, enhanced social distancing and sanitary practices, and frequent disinfection with emergency supplies of personal protective equipment, antiseptics and all necessary medical equipment.

Despite the safety measures and protocols that are in place, several KATCO employees who had tested negative when arriving at the site at the end of December, began to show symptoms of COVID-19 while working at the facility and staying in the Moinkum camp. The operation's senior management promptly moved to conduct PCR testing of all KATCO employees and contractors, which resulted in the identification of additional positive cases.

Based on recommendations of local medical authorities, and in light of positive cases among site personnel that had previously tested negative, testing of all employees and contractors at Tortkuduk camp was carried. Final test results from both camps are still pending. Affected personnel have been isolated. According to the protocol of Chief state sanitary doctor of Suzak area, Turkistan region, both facilities have been placed under quarantine to await final results prior to a shift change. The Company is taking all necessary measures to ensure the health and well-being of personnel both on and off the sites.

KATCO does not expect the site quarantine to have an impact on drilling or planned 2021 production, given the camp layouts and a separation between workers involved in wellfield development and those involved in production.

The Company continues to monitor the situation at all of its operations and will remain in strict compliance with governmental directives in relation to COVID-19, ensuring that all necessary actions to reduce the spread and/or impact of the pandemic are implemented without delay.

For further information, please contact:

Kazatomprom Investor Relations Inquiries

Cory Kos, Director of Investor Relations

Tel: +7 (8) 7172 45 81 80

Email: ir@kazatomprom.kz 

Kazatomprom Public Relations and Media Inquiries

Torgyn Mukayeva, Chief Expert of GR and PR department

Tel: +7 (8) 7172 45 80 63

Email: pr@kazatomprom.kz 

About Kazatomprom

Kazatomprom is the world's largest producer of uranium, with the company's attributable production representing approximately 24% of global primary uranium production in 2019. The Group benefits from the largest reserve base in the industry and operates, through its subsidiaries, JVs and Associates, 26 deposits grouped into 14 mining assets. All of the Company's mining operations are located in Kazakhstan and mined using ISR technology with a focus on maintaining industry-leading health, safety and environment standards.

Kazatomprom securities are listed on the London Stock Exchange and Astana International Exchange. As the national atomic company in the Republic of Kazakhstan, the Group's primary customers are operators of nuclear generation capacity, and the principal export markets for the Group's products are China, South and Eastern Asia, Europe and North America. The Group sells uranium and uranium products under long-term contracts, short-term contracts, as well as in the spot market, directly from its headquarters in Nur-Sultan, Kazakhstan, and through its Switzerland-based trading subsidiary, Trade House KazakAtom AG (THK).

For more information, please see the Company's website at http://www.kazatomprom.kz

Forward-looking statements

All statements other than statements of historical fact included in this communication or document are forward-looking statements. Forward-looking statements give the Company's current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target," "believe," "expect," "aim," "intend," "may," "anticipate," "estimate," "plan," "project," "will," "can have," "likely," "should," "would," "could" and other words and terms of similar meaning or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the Company's actual results, performance or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which it will operate in the future. THE INFORMATION WITH RESPECT TO ANY PROJECTIONS PRESENTED HEREIN IS BASED ON A NUMBER OF ASSUMPTIONS ABOUT FUTURE EVENTS AND IS SUBJECT TO SIGNIFICANT ECONOMIC AND COMPETITIVE UNCERTAINTY AND OTHER CONTINGENCIES, NONE OF WHICH CAN BE PREDICTED WITH ANY CERTAINTY AND SOME OF WHICH ARE BEYOND THE CONTROL OF THE COMPANY. THERE CAN BE NO ASSURANCES THAT THE PROJECTIONS WILL BE REALISED, AND ACTUAL RESULTS MAY BE HIGHER OR LOWER THAN THOSE INDICATED. NONE OF THE COMPANY NOR ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, ADVISORS OR AFFILIATES, OR ANY REPRESENTATIVES OR AFFILIATES OF THE FOREGOING, ASSUMES RESPONSIBILITY FOR THE ACCURACY OF THE PROJECTIONS PRESENTED HEREIN. The information contained in this communication or document, including but not limited to forward-looking statements, applies only as of the date hereof and is not intended to give any assurances as to future results. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to such information, including any financial data or forward-looking statements, and will not publicly release any revisions it may make to the Information that may result from any change in the Company's expectations, any change in events, conditions or circumstances on which these forward-looking statements are based, or other events or circumstances arising after the date hereof.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBDGDBXDDDGBG
Date   Source Headline
23rd Sep 20198:00 amRNSInclusion of KAP's bonds in KASE official list
19th Sep 20197:00 amRNSExpantion of Board Committee Members
27th Aug 20197:00 amRNSKazatomprom 1H19 Financial Results
20th Aug 20197:14 amRNSKazatomprom announces extension of production cuts
1st Aug 20197:06 amRNSKazatomprom 2Q19 Operations and Trading Update
29th Jul 20197:01 amRNSKAP announces first Capital Markets Day
15th Jul 20197:00 amRNSKAP response to Section 232 decision
28th Jun 20197:00 amRNSReport on Payments to Goverments
31st May 20197:00 amRNSAGM Results
28th May 20197:00 amRNS3M 2019 financial results
20th May 20197:00 amRNSKazatomprom sells 75% ownership interest in KAZ PV
16th May 20197:00 amRNSKAP reaches agreement with ENUSA News Release
15th May 201912:10 pmRNSNotice of additional item to the agenda of the AGM
2nd May 20197:11 amRNSKazatomprom 19Q1 Operations and Trading Update
30th Apr 201912:48 pmRNSAGM,AR and Dividend Recommendation News Release
30th Apr 20197:20 amRNSIntegrated Annual Report 2018
30th Apr 20197:07 amRNSAGM, AR and Dividend Recommendation News Release
18th Mar 201911:12 amRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSKazatomprom 2018 Annual Financial Results
28th Feb 20197:00 amRNSKazatomprom informs on approval of audit partner
1st Feb 20197:00 amRNSKazatomprom 18Q4 Operations and Trading Update
14th Dec 20187:10 amRNSBaiken Khorasan acquisition - Kazatomprom
12th Dec 20187:31 amRNSStatement re: KASE
7th Dec 20185:24 pmRNSExercise of Greenshoe - Kazatomprom
30th Nov 20184:42 pmRNSPost Stabilisation Notice - Kazatomprom
27th Nov 201811:26 amRNSMid Stabilisation Notice - Kazatomprom IPO
20th Nov 201810:11 amRNSMid Stabilisation Notice - Kazatomprom IPO
16th Nov 201811:25 amRNSDirector/PDMR Shareholding
16th Nov 201811:25 amRNSDirector/PDMR Shareholding
13th Nov 20182:10 pmRNSCorrection - KZT Exchange Rate and KZT Offer Price
13th Nov 20187:44 amRNSPre Stab Notice - Kazatomprom
13th Nov 20187:41 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.